CLINICAL_TRIALS
trial_result
· 2025-12-09
Clinical Trial Update: A Study of RBD1016 in CHB Participants [Phase 2]
Summary
Phase 2 study of RBD1016 in participants with chronic hepatitis B has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Suzhou Ribo Life Science Co. Ltd. | Conditions: Chronic Hepatitis b | Phase 2 | Status: COMPLETED